These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23351020)

  • 21. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.
    Schaefer L; Tsalastra W; Babelova A; Baliova M; Minnerup J; Sorokin L; Gröne HJ; Reinhardt DP; Pfeilschifter J; Iozzo RV; Schaefer RM
    Am J Pathol; 2007 Jan; 170(1):301-15. PubMed ID: 17200203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.
    Sarfstein R; Pasmanik-Chor M; Yeheskel A; Edry L; Shomron N; Warman N; Wertheimer E; Maor S; Shochat L; Werner H
    J Biol Chem; 2012 Jan; 287(4):2766-76. PubMed ID: 22128190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A candidate targeting molecule of insulin-like growth factor-I receptor for gastrointestinal cancers.
    Adachi Y; Yamamoto H; Ohashi H; Endo T; Carbone DP; Imai K; Shinomura Y
    World J Gastroenterol; 2010 Dec; 16(46):5779-89. PubMed ID: 21154998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor.
    Brisson BK; Barton ER
    PLoS One; 2012; 7(9):e45588. PubMed ID: 23029120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer.
    Cao HY; Guo XF; Zhu XF; Li SS; Zhen YS
    Oncol Rep; 2017 Jun; 37(6):3329-3340. PubMed ID: 28498434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.
    Niu XL; Li J; Hakim ZS; Rojas M; Runge MS; Madamanchi NR
    J Biol Chem; 2007 Jul; 282(27):19808-19. PubMed ID: 17500057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The IGF axis and hepatocarcinogenesis.
    Scharf JG; Dombrowski F; Ramadori G
    Mol Pathol; 2001 Jun; 54(3):138-44. PubMed ID: 11376124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.
    Fukushima T; Nakamura Y; Yamanaka D; Shibano T; Chida K; Minami S; Asano T; Hakuno F; Takahashi S
    J Biol Chem; 2012 Aug; 287(35):29713-21. PubMed ID: 22767591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
    Shi P; Lai R; Lin Q; Iqbal AS; Young LC; Kwak LW; Ford RJ; Amin HM
    Blood; 2009 Jul; 114(2):360-70. PubMed ID: 19423729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible expression of dominant negative insulin-like growth factor I receptor in MCF-7 breast cancer cells.
    Modha G; Blanchard A; Sidorchuk J; Venditti M; Shiu R; Myal Y
    Endocrine; 2003 Dec; 22(3):293-303. PubMed ID: 14709803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
    Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA
    Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factors in endometrial function.
    Rutanen EM
    Gynecol Endocrinol; 1998 Dec; 12(6):399-406. PubMed ID: 10065165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
    Kolychev AP
    Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
    J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localization of insulin-like growth factor system in corpus luteum during different stages of estrous cycle in water buffaloes (Bubalus bubalis) and the effect of insulin-like growth factor I on production of vascular endothelial growth factor and progesterone in luteal cells cultured in vitro.
    Uniyal S; Panda RP; Chouhan VS; Yadav VP; Hyder I; Dangi SS; Gupta M; Khan FA; Sharma GT; Bag S; Sarkar M
    Theriogenology; 2015 Jan; 83(1):58-77. PubMed ID: 25304995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
    Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
    Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.
    Forbes BE
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):374-81. PubMed ID: 21972777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.